Following this achievement, Aspivix has obtained approval from the Medicines & Healthcare products Regulatory Agency (MHRA) for use in the United Kingdom. A non-invassive solution, Carevix, offers a more comfortable and empowering experience for patients and healthcare providers alike for transcervical procedures in gynecology, oncology and fertility, including IUD/coil insertions. As Aspivix continues to expand its presence in the UK market, the approval of Carevix by the MHRA is a testament to Aspivix's dedication to excellence and innovation in healthcare.
The first patient who benefitted from Aspivix’s carevix™, in the United Kingdom experienced a successful coil-fitting procedure performed by Dr. Lukasz Polanski, MD., an esteemed member of the Royal College of Obstetricians and Gynecologists at the Peterborough City Hospital – North West Anglia NHS Foundation Trust. Peterborough City Hospital has now become the first Ambassador offering a painless contraceptive care in the United Kingdom. Over 600 patients have benefitted from the use of the Carevix worldwide as part of the Ambassador Program using Carevix in routine. The startup already has FDA-clearance for the US market and the CE-mark for Europe.
Biospectal live in Play Store UK
With OptiBP, Biospectal offers the world's first and only medically certified blood pressure monitor app that uses a smartphone camera to measure blood pressure. The app aims to revolutionize hypertension management by making blood pressure monitoring more convenient and accessible, potentially improving heart health outcomes worldwide. Biospecta has now launched the CE MDR Class IIa medical certified app in the UK Paystore.
betterview opens first store
After almost 8 months of intensive founding, preparation and construction, betterview has opened its first shop in Westfield London in White City, UK. The Swiss startup provides laser eye surgery, offering a range of vision correction treatments. In Switzerland, betterview operates in ten regions, including cities like Zurich, Bern, Lausanne, and Basel and has conducted more than 10,000 successful treatments.
(RAN)